Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGS - Nasdaq Real Time Price USD

Lexicon Pharmaceuticals, Inc. (LXRX)

Compare
0.4641
+0.0033
+(0.72%)
At close: April 1 at 4:00:02 PM EDT
0.4650
+0.00
+(0.19%)
After hours: April 1 at 7:58:58 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
31,081
31,081
1,204
139
298
Cost of Revenue
616
616
85
--
--
Gross Profit
30,465
30,465
1,119
139
298
Operating Expense
227,582
227,582
172,869
100,899
87,388
Operating Income
-197,117
-197,117
-171,750
-100,760
-87,090
Net Non Operating Interest Income Expense
-3,286
-3,286
-5,369
-1,184
-668
Pretax Income
-200,403
-200,403
-177,119
-101,944
-87,758
Net Income Common Stockholders
-200,403
-200,403
-177,119
-101,944
-87,758
Diluted NI Available to Com Stockholders
-200,403
-200,403
-177,119
-101,944
-87,758
Basic EPS
-0.63
--
-0.79
-0.62
-0.60
Diluted EPS
-0.63
--
-0.79
-0.62
-0.60
Basic Average Shares
320,031
--
221,130
165,733
145,652
Diluted Average Shares
320,031
--
221,130
165,733
145,652
Total Operating Income as Reported
-197,117
-197,117
-171,750
-100,760
-87,090
Total Expenses
228,198
228,198
172,954
100,899
87,388
Net Income from Continuing & Discontinued Operation
-200,403
-200,403
-177,119
-101,944
-87,758
Normalized Income
-200,403
-200,403
-177,119
-101,944
-87,758
Interest Income
12,293
12,293
7,732
1,596
134
Interest Expense
15,579
15,579
13,101
2,780
802
Net Interest Income
-3,286
-3,286
-5,369
-1,184
-668
EBIT
-184,824
-184,824
-164,018
-99,164
-86,956
EBITDA
-184,290
-184,290
-163,464
-98,737
-86,664
Reconciled Cost of Revenue
616
616
85
--
--
Reconciled Depreciation
534
534
554
427
292
Net Income from Continuing Operation Net Minority Interest
-200,403
-200,403
-177,119
-101,944
-87,758
Normalized EBITDA
-184,290
-184,290
-163,464
-98,737
-86,664
12/31/2021 - 4/7/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PRTG Portage Biotech Inc.
8.26
-10.70%
 
OCEA Ocean Biomedical, Inc.
0.0549
+1.67%
 
OSRH OSR Holdings, Inc.
1.7200
-8.51%
 
DBVT DBV Technologies S.A.
6.46
-5.28%
 
DRMA Dermata Therapeutics, Inc.
0.9997
-7.44%
 
THTX Theratechnologies Inc.
1.4000
0.00%
 
SNSE Sensei Biotherapeutics, Inc.
0.3450
-12.44%
 
PSTV Plus Therapeutics, Inc.
1.0200
+7.36%
 
LPTX Leap Therapeutics, Inc.
0.2913
-4.52%
 
RNAZ TransCode Therapeutics, Inc.
0.5409
+9.27%